Download PDF
Exp Clin Endocrinol Diabetes 1984; 83(2): 136-142
DOI: 10.1055/s-0029-1210322
Original

© J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New York

Results of Treatment with Continuous Subcutaneous Insulin Infusion (CSII) in Insulin-Dependent (Type I) Diabetics

W. Felsing1 , H. Bibergeil1 , R. Menzel1 , G. Albrecht1 , U. Felsing1 , J. Dabels2 , G. Reichel3 , C. Lüder1
  • 1Central Institute of Diabetes “Gerhardt Katsch” Karlsburg
  • 2Department of Internal Medicine, Wilhelm Pieck University Rostock
  • 3Department of Neurology, Ernst Moritz Arndt University Greifswald/GDR
Further Information

Publication History

1983

Publication Date:
17 July 2009 (online)

Also available at
  PDF Download  Permissions and Reprints

Summary

10 labile insulin-dependent diabetic patients treated with CSII were followed up for 6 to 16 months under conditions of everyday life. The mean blood glucose (MBG), glycosylated haemoglobin (HbA1), motor nerve conduction velocity (MCV), and respiratory heart arrhythmia at rest (RHA) were investigated. A significant improvement of metabolic control was observed (MBG 8.03 ± 1.40 vs 5.18 ± 0.87 mmol/1, p < 0.01; HbA1 10.7 ± 1.3 vs 8.7 ± 1.6%, p < 0.05) in comparison with the control values under intensified conventional therapy. MCV increased gradually but the average RHA remained unchanged. The psychological examination employing a questionnaire reflects that all patients selected were highly motivated and that their positive attitudes were further stabilized during pump treatment. An average of three mild hypoglycaemic episodes occurred per month per patient; these were no more than under intensified conventional treatment. Other minor clinical and technical complications occurred at a total frequency of one per month per patient and did not achieve therapeutical relevance.

Key words

Type I diabetes - continuous insulin infusion - diabetic neuropathy